Home
About
Overview
Sharing Data
ORCID
Help
History (9)
The role of biologics in ulcerative colitis.
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis.
Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.
Predicting school readiness from neurodevelopmental assessments at age 2 years after respiratory distress syndrome in infants born preterm.
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol. 2007 Apr; 102(4):794-802.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Chi-Square Distribution
Colitis, Ulcerative
Double-Blind Method
Female
Gastrointestinal Agents
Humans
Infliximab
Male
Placebos
Quality of Life
Surveys and Questionnaires
Treatment Outcome
authors with profiles
Stephen B. Hanauer